Upadacitinib Versus Filgotinib in Ulcerative Colitis: Is the Evidence Sufficient to Inform Treatment Decisions?
United European Gastroenterol J
.
2024 Nov 13.
doi: 10.1002/ueg2.12709.
Online ahead of print.
Authors
Sudheer Kumar Vuyyuru
1
,
Yuhong Yuan
1
2
,
Vipul Jairath
1
2
3
Affiliations
1
Department of Medicine, Division of Gastroenterology, Western University, London, Canada.
2
Lawson Health Research Institute, Western University, London, Canada.
3
Department of Epidemiology and Biostatistics, Western University, London, Canada.
PMID:
39535345
DOI:
10.1002/ueg2.12709
No abstract available
Publication types
Editorial